MAIA Biotechnology, Inc.

As of June 5, 2025, the market trend is mildly bearish due to bearish signals from the monthly MACD and RSI, despite some mildly bullish indicators on the weekly timeframe.

MAIA Biotechnology, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $50.31 million. Key financial metrics include a negative P/E ratio, a debt equity ratio of -2.20, and a return on equity of -366.01%.

As of Jun 18, MAIA Biotechnology, Inc. has a market capitalization of 50.31 million and reported net sales of 0.00 million with a net profit of -19.71 million over the last four quarters.